Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Liang We
Emerging Technologies to Achieve Oral Delivery of GLP-1 and GLP-1 Analogs for Treatment of Type 2 Diabetes Mellitus (T2DM)
Canadian Journal of Biotechnology
Related publications
Semaglutide: A New GLP‐1 Analogue for Type 2 Diabetes
Prescriber
Pharmacology
Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Dulaglutide: Third Once-Weekly GLP-1 Agonist for Type 2 Diabetes
Pharmacy Today
GLP-1 Based Therapeutics: Simultaneously Combating T2DM and Obesity
Frontiers in Neuroscience
Neuroscience
Discovery of Novel and Long Acting GLP-1 Analogs
Pdb68 - Cost-Effectiveness Analysis of Exenatide Versus GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
366. Combining Delivery of GLP-1 Gene Expressing Plasmid and DPP-4 Gene Silencing siRNA Using Chitosan-Based Nanoparticles for Type-2 Diabetes Treatment
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Patient Preferences for Frequency of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Injections in the Treatment of Type 2 Diabetes
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Effects of GLP-1 Analogues in Obese, Insulin-Using Type 2 Diabetes in Relation to Eating Behaviour
International Journal of Clinical Pharmacy
Toxicology
Pharmacy
Pharmacology
Pharmaceutical Science
